Clinical Trial

A Study of Depemokimab in Participants of 6 to 11 Years of Age

Name: A Study of Depemokimab in Participants of 6 to 11 Years of Age — clinical trial record (NCT07671001)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GLIDE

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study is aimed at assessing depemokimab as an add-on medicine for the treatment of asthma with type-2 inflammation in participants of 6 to 11 years of age. This study will test how the body processes depemokimab, how the drug works in the body, and its safety and tolerability.

Trial Details

NCT Number	NCT07671001
Lead Sponsor	GlaxoSmithKline
Conditions	Asthma
Enrollment	30 participants
Start Date	2026-06-26
Primary Completion	2029-03-19 (estimated)
Study Completion	2029-03-19 (estimated)
Updated on ClinicalTrials.gov	2026-06-26